AH Capital Management
Latest statistics and disclosures from a16z Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NAVN, FIG, META, RVMD, NAUT, and represent 76.84% of a16z Capital Management's stock portfolio.
- Added to shares of these 5 stocks: DMRA (+$32M), NAVN (+$14M), Aktis Oncology (+$7.4M), Bitgo Holdings (+$5.5M), IPST.
- Started 4 new stock positions in DMRA, IPST, Bitgo Holdings, Aktis Oncology.
- Reduced shares in these 3 stocks: OMDA (-$15M), FIG, HTBK.
- Sold out of its position in HTBK.
- a16z Capital Management was a net buyer of stock by $39M.
- a16z Capital Management has $1.3B in assets under management (AUM), dropping by -18.30%.
- Central Index Key (CIK): 0001540358
Tip: Access up to 7 years of quarterly data
Positions held by AH Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for a16z Capital Management
a16z Capital Management holds 16 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Navan Cl A (NAVN) | 28.9 | $374M | +3% | 28M | 13.24 |
|
| Figma Class A Com Stk (FIG) | 26.2 | $339M | 16M | 21.14 |
|
|
| Meta Platforms Cl A (META) | 9.4 | $122M | 213k | 572.13 |
|
|
| Revolution Medicines (RVMD) | 6.9 | $90M | 921k | 97.25 |
|
|
| Nautilus Biotechnology (NAUT) | 5.3 | $69M | 18M | 3.88 |
|
|
| Block Cl A (XYZ) | 4.7 | $61M | 1.0M | 60.18 |
|
|
| Bioage Labs (BIOA) | 4.4 | $57M | 3.2M | 17.49 |
|
|
| Maze Therapeatics (MAZE) | 3.9 | $51M | 1.7M | 29.85 |
|
|
| Erasca (ERAS) | 3.6 | $46M | 2.9M | 16.18 |
|
|
| Damora Therapeutics Com New (DMRA) | 2.5 | $32M | NEW | 1.2M | 25.90 |
|
| Omada Health (OMDA) | 2.2 | $29M | -33% | 2.3M | 12.57 |
|
| Camp4 Therapeutics Corp (CAMP) | 0.7 | $9.4M | 2.1M | 4.41 |
|
|
| Aktis Oncology | 0.6 | $7.4M | NEW | 415k | 17.89 |
|
| Bitgo Holdings Com Shs Cl A | 0.4 | $5.5M | NEW | 666k | 8.23 |
|
| Ginkgo Bioworks Holdings Cl A New (DNA) | 0.1 | $666k | 109k | 6.13 |
|
|
| Heritage Distilling Hldg (IPST) | 0.0 | $22k | NEW | 83k | 0.26 |
|
Past Filings by a16z Capital Management
SEC 13F filings are viewable for a16z Capital Management going back to 2023
- a16z Capital Management 2026 Q1 filed May 15, 2026
- a16z Capital Management 2025 Q4 filed Feb. 17, 2026
- a16z Capital Management 2025 Q3 filed Nov. 14, 2025
- AH Capital Management 2025 Q2 filed Aug. 14, 2025
- AH Capital Management 2025 Q1 filed May 15, 2025
- AH Capital Management 2024 Q4 filed Feb. 12, 2025
- AH Capital Management 2024 Q3 filed Nov. 13, 2024
- AH Capital Management 2024 Q2 filed Aug. 13, 2024
- AH Capital Management 2023 Q4 restated filed May 15, 2024
- AH Capital Management 2024 Q1 filed May 15, 2024
- AH Capital Management 2023 Q4 filed Feb. 14, 2024